Perspective TherapeuticsCATX
13F holders, Q3 2025 (September 30)2holders
0new positions
0sold out
$3.43avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Perspective Therapeutics Inc. (CATX) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Vestor Capital, LLC ($3.3M) and Portland Investment Counsel Inc. ($858K).
- Company
- Perspective Therapeutics Inc.
- CUSIP
- 46489V104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 970,875 shares bought, net +970,875 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Vestor Capital, LLC | 0.21% | Add +88181.2% | 971,976 | $3.3M |
| Portland Investment Counsel Inc. | 0.23% | No change | 250,000 | $858K |
"% of holder's portfolio" is CATX's weight in each manager's 13F, not the share of Perspective Therapeutics Inc. the manager owns.